| POLAR CAPITAL BIOTECHNOLOGY S USD DIS | RVI BIOTECNOLOGÍA | 62,11% | 72,79% | 84,46% | 383,26% |
| JPM JAPAN EQUITY C (ACC) USD (HEDGED) | RVI JAPÓN | 39,41% | 103,75% | 135,61% | 383,20% |
| POLAR CAPITAL BIOTECHNOLOGY S GBP DIS | RVI BIOTECNOLOGÍA | 61,75% | 72,11% | 83,25% | 382,91% |
| INVESCO JPX-NIKKEI 400 UCITS ETF USD HEDGED ACC | RVI JAPÓN | 52,29% | 100,75% | 183,08% | 382,32% |
| POLAR CAPITAL BIOTECHNOLOGY S EUR DIS | RVI BIOTECNOLOGÍA | 61,75% | 71,76% | 83,40% | 382,05% |
| MULTIUNITS LUX - AMUNDI EURO STOXX BANKS UCITS ETF ACC EUR | RVI FINANCIERO | 57,37% | 227,86% | 311,71% | 381,98% |
| BNP PARIBAS US GROWTH I CAP | RVI USA CRECIMIENTO | 31,62% | 74,16% | 90,92% | 381,91% |
| GAM STAR DISRUPTIVE GROWTH INSTITUTIONAL EUR CAP | RVI TECNOLOGÍA | 34,50% | 75,18% | 32,48% | 381,28% |
| BGF WORLD FINANCIALS D2 EUR | RVI FINANCIERO | 27,64% | 118,98% | 120,38% | 380,18% |
| ISHARES MSCI JAPAN USD HEDGED UCITS ETF (ACC) | RVI JAPÓN | 56,61% | 102,68% | 181,10% | 380,02% |
| BGF WORLD FINANCIALS D2 USD | RVI FINANCIERO | 27,65% | 118,99% | 120,83% | 379,28% |
| JANUS HENDERSON US FORTY H2 USD | RVI USA CRECIMIENTO | 22,86% | 73,55% | 70,78% | 378,87% |
| BNP PARIBAS US GROWTH PRIVILEGE CAP | RVI USA CRECIMIENTO | 31,49% | 73,61% | 89,88% | 375,55% |
| SCHRODER ISF JAPANESE OPPORTUNITIES C ACC USD (HEDGED) | RVI JAPÓN VALOR | 63,30% | 109,06% | 195,42% | 374,98% |
| PRIVILEDGE - ALPHA JAPAN (EUR) N CAP SYST. HDG | RVI JAPÓN | 44,86% | 109,89% | 152,29% | 370,60% |
| UBS (LUX) EQUITY FUND - TECH OPPORTUNITY (USD) (CHF HEDGED) Q-ACC | RVI TECNOLOGÍA | 29,61% | 68,60% | 48,13% | 370,50% |
| JPM KOREA EQUITY A (ACC) EUR | RVI COREA | 153,58% | 177,73% | 120,15% | 370,35% |
| SPDR MSCI EUROPE TECHNOLOGY UCITS ETF | RVI TECNOLOGÍA | 64,70% | 89,71% | 97,15% | 370,05% |
| POLAR CAPITAL BIOTECHNOLOGY I USD DIS | RVI BIOTECNOLOGÍA | 61,70% | 71,11% | 81,59% | 369,81% |
| VANGUARD U.S. OPPORTUNITIES INSTITUTIONAL USD CAP | RVI USA | 61,49% | 90,67% | 105,91% | 369,58% |
